Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon Tan P, Tickoo SK, Tsuzuki T, Turajlic S, Cree I, Berney DM (2022)
Publication Type: Journal article
Publication year: 2022
DOI: 10.1016/j.eururo.2022.09.015
APA:
Netto, G.J., Amin, M.B., Compérat, E.M., Gill, A.J., Hartmann, A., Moch, H.,... Berney, D.M. (2022). Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. European Urology. https://doi.org/10.1016/j.eururo.2022.09.015
MLA:
Netto, George J., et al. "Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification." European Urology (2022).
BibTeX: Download